Annual CFO
-$59.27 M
-$19.19 M-47.88%
December 31, 2023
Summary
- As of February 7, 2025, SPRY annual cash flow from operations is -$59.27 million, with the most recent change of -$19.19 million (-47.88%) on December 31, 2023.
- During the last 3 years, SPRY annual CFO has fallen by -$68.34 million (-753.36%).
- SPRY annual CFO is now -753.36% below its all-time high of $9.07 million, reached on December 1, 2020.
Performance
SPRY Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$14.47 M
-$7.19 M-98.75%
September 30, 2024
Summary
- As of February 7, 2025, SPRY quarterly cash flow from operations is -$14.47 million, with the most recent change of -$7.19 million (-98.75%) on September 30, 2024.
- Over the past year, SPRY quarterly CFO has dropped by -$7.19 million (-98.75%).
- SPRY quarterly CFO is now -154.61% below its all-time high of -$5.68 million, reached on September 1, 2022.
Performance
SPRY Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$45.86 M
-$1.70 M-3.86%
September 30, 2024
Summary
- As of February 7, 2025, SPRY TTM cash flow from operations is -$45.86 million, with the most recent change of -$1.70 million (-3.86%) on September 30, 2024.
- Over the past year, SPRY TTM CFO has dropped by -$1.70 million (-3.86%).
- SPRY TTM CFO is now -562.25% below its all-time high of -$6.92 million, reached on March 31, 2022.
Performance
SPRY TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
SPRY Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -47.9% | -98.8% | -3.9% |
| 3 y3 years | -753.4% | -98.8% | -3.9% |
| 5 y5 years | -753.4% | -98.8% | -3.9% |
SPRY Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -237.5% | at low | -154.6% | +29.4% | -562.3% | +26.5% |
| 5 y | 5-year | -753.4% | at low | -154.6% | +29.4% | -562.3% | +26.5% |
| alltime | all time | -753.4% | at low | -154.6% | +29.4% | -562.3% | +26.5% |
ARS Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$14.47 M(+98.7%) | -$45.86 M(+3.9%) |
| Jun 2024 | - | -$7.28 M(+8.5%) | -$44.16 M(-17.5%) |
| Mar 2024 | - | -$6.71 M(-61.4%) | -$53.55 M(-9.6%) |
| Dec 2023 | -$59.27 M | -$17.41 M(+36.4%) | -$59.27 M(-5.0%) |
| Sep 2023 | - | -$12.76 M(-23.4%) | -$62.36 M(+12.8%) |
| Jun 2023 | - | -$16.67 M(+34.1%) | -$55.28 M(+21.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$12.43 M(-39.4%) | -$45.58 M(+13.7%) |
| Dec 2022 | -$40.08 M(+128.2%) | -$20.50 M(+260.7%) | -$40.08 M(+104.7%) |
| Sep 2022 | - | -$5.68 M(-18.5%) | -$19.58 M(+40.9%) |
| Jun 2022 | - | -$6.97 M(+0.7%) | -$13.90 M(+100.7%) |
| Mar 2022 | - | -$6.92 M | -$6.92 M |
| Dec 2021 | -$17.56 M(-293.6%) | - | - |
| Dec 2020 | $9.07 M | - | - |
FAQ
- What is ARS Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals annual CFO year-on-year change?
- What is ARS Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals quarterly CFO year-on-year change?
- What is ARS Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals TTM CFO year-on-year change?
What is ARS Pharmaceuticals annual cash flow from operations?
The current annual CFO of SPRY is -$59.27 M
What is the all time high annual CFO for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high annual cash flow from operations is $9.07 M
What is ARS Pharmaceuticals annual CFO year-on-year change?
Over the past year, SPRY annual cash flow from operations has changed by -$19.19 M (-47.88%)
What is ARS Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of SPRY is -$14.47 M
What is the all time high quarterly CFO for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high quarterly cash flow from operations is -$5.68 M
What is ARS Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, SPRY quarterly cash flow from operations has changed by -$7.19 M (-98.75%)
What is ARS Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of SPRY is -$45.86 M
What is the all time high TTM CFO for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high TTM cash flow from operations is -$6.92 M
What is ARS Pharmaceuticals TTM CFO year-on-year change?
Over the past year, SPRY TTM cash flow from operations has changed by -$1.70 M (-3.86%)